1. What are the implications of June’s Supreme Court decision on the future of healthcare delivery?

2. What will Obama/Romney aim to accomplish over the next four years with respect to healthcare legislation?

3. How are different stakeholders (e.g. providers, payers) responding and altering their strategy accordingly?

David Dranove (Moderator) Professor, Kellogg School of Management
David Dranove  

David Dranove is the Walter McNerney Professor of Health Industry Management at Northwestern University’s Kellogg School of Management, where he is also Professor of Management and Strategy and Director of the Center for Health Industry Market Economics. He has a PhD in Economics from Stanford University.


Professor Dranove’s research focuses on problems in industrial organization and business strategy with an emphasis on the health care industry. He has published nearly 75 research articles and book chapters and written five books, including The Economic Evolution of American Healthcare and What’s Your Life Worth? His textbook, The Economics of Strategy, is used by leading business schools around the world. His latest book, Code Red, was published by Princeton University Press in 2008.

Kevin Cassidy '08, VP National Accounts, Blue Cross and Blue Shield of Illinois
Kevin Cassidy  

Kevin Cassidy is vice president of national and major accounts for Blue Cross and Blue Shield of Illinois (BCBSIL.) Mr. Cassidy is responsible for national account sales, national and key account management, inter-plan business solutions, the HCSC Blue Card executive and proposal management. His team oversees benefit plans for the company’s existing business, which includes health plans for approximately 300 major account customers whose business represents more than 3.5 million Blue Cross members.


Mr. Cassidy joined BCBSIL in 1992 and has served in national and major accounts since 1994. Prior to his current position as vice president, Mr. Cassidy was director of national account sales and held positions in government contracts, operations and account management.


Mr. Cassidy holds a Bachelor’s Degree in Communication and Economics from Illinois State University and a Master’s Degree in Business Administration from the Kellogg School of Management at Northwestern University.


Mr. Cassidy currently serves on the board of the local non-profit, “I Want to Walk the Talk”, which promotes developing healthy lifestyle habits through community-oriented programs. A Chicagoland native, Mr. Cassidy lives with his wife and three children in the Chicago area.

Katy Pinter '05, Principal, The Chartis Group
Katy Pinter  

Katy Pinter is a Principal with The Chartis Group. Her experience in healthcare spans more than 12 years assisting leading regional health systems, academic medical centers, children’s hospitals, community hospitals, payers and healthcare suppliers in achieving their strategic and financial imperatives. Her strategic experience spans the areas of enterprise and service line strategic planning, accountable care readiness, population health management, physician network design, mergers and acquisitions, and facilities planning. Ms. Pinter’s operations experience has been focused in perioperative redesign involving strategic goal setting, process redesign, role definition, communications, and performance monitoring. Ms. Pinter has also done alignment work and faculty compensation benchmarking with academic medical centers.


Ms. Pinter’s professional experience includes consulting for Authoria Inc, a human resources/benefits information technology company; account management and product development for ChannelPoint Inc, a healthcare technology company; strategic planning and business development for Johnson & Johnson, and product marketing for Abbott Laboratories.


Ms. Pinter has her MBA from the Kellogg School of Management at Northwestern University, where she concentrated her studies in Strategy, Marketing, Health Industry Management, and Organizational Behavior. She has her B.S. in Economics from The Wharton School at University of Pennsylvania, where she majored in Marketing and Healthcare Management.

Josh Soven, Former Chief of Litigation, US Dept. of Justice
Josh Soven  

Josh Soven is a partner at Gibson, Dunn & Crutcher LLP.


From 2007 to 2012, Mr. Soven served as Chief of the Litigation I Section of the Antitrust Division of the Department of Justice. In this role, he oversaw a team responsible for investigating and prosecuting merger and non-merger antitrust violations in the insurance, health care, consumer products, paper and dairy sectors.


From 2004 to 2007, he worked at the FTC, as Attorney Advisor to Chairman Deborah Platt Majoras, where he advised on antitrust enforcement and policy matters. From 1998 to 2004, he served as Trial Attorney in the Networks and Technology Enforcement Section of the Antitrust Division of the DOJ.


Mr. Soven currently serves as a Senior Editor of the Antitrust Law Journal. He previously served as Vice Chair of the Federal Civil Enforcement Committee of the ABA’s Antitrust Section. He has served as a Lecturer at the Kellogg School of Management at Northwestern University, co-teaching a course on strategy and competition policy in the health care sector.


Mr. Soven also served as a Special Assistant U.S. Attorney with the U.S. Attorney’s Office in the Eastern District of Virginia. Mr. Soven is a 1991 graduate of the University of Virginia School of Law.


1. With the increasing interest in providing healthcare services to international emerging markets, how do companies design innovative approaches?

2. How do for-profit firms design pricing strategies to provide healthcare access to all tiers of these emerging economies? How do they deal with specific international policy issues?

3. How do they envision changes in the public-private partnerships in the next 5 years?

Kara Palamountain '04 (Moderator) Executive Director of the Kellogg School of Management’s Global Health Initiative (GHI)
Kara Palamountain  

Kara Palamountain is executive director of the Kellogg School of Management’s Global Health Initiative (GHI). Ms. Palamountain has managed over 300 Kellogg MBA students conducting market entry analysis for new medical technologies in over a dozen African and Asian countries. As President of the Northwestern Global Health Foundation she is responsible for launching a new infant HIV test in 10 African and Asian countries in 2013. This test will reduce the time a mother must wait for a test result from 4 months to less than 30 minutes.


Ms. Palamountain has an MBA from the Kellogg School of Management at Northwestern University.

Kanika Bahl, Managing Director, Results for Development


Kanika Bahl is a Principal and Managing Director at Results for Development Institute (R4D), where she founded and leads the Market Dynamics practice.

R4D’s Market Dynamics practice has developed strategies to achieve over a billion dollars in efficiency savings and ensure sustainable availability of high-quality products to address malnutrition, AIDS, malaria, and neglected diseases. In this role, Kanika has successfully engaged with Fortune 500 companies, major global financiers including the Global Fund and the Gates Foundation, and country governments across Africa, Asia, and Latin America. Her work has been cited in various international publications including The Guardian and Huffington Post.   Kanika recently co-chaired the Market-Shaping group for the UN Commission on Life-Saving Commodities for Women and Children. 

Prior to R4D, Kanika served as an Executive Vice President at the Clinton Foundation Health Access Initiative (CHAI), where she worked from 2005-2010. While there, she helped build and lead the $400 million, 33 country UNITAID program which reduced prices on HIV/AIDS drugs by 80% for over 2 million global patients.  She also served as Africa Regional Director, launching and managing CHAI’s presence in 19 sub-Saharan African countries. Prior to CHAI, Kanika led market-based approaches to international development across a variety of sectors including technology, infrastructure, and financial services. She worked at Voxiva, Bechtel Enterprises and the Consultative Group to Assist the Poor (CGAP), a leading microfinance organization.

Kanika received her MBA from the Stanford Graduate School of Business and her BA in Mathematical Economics from Rice University.

Mitch Higashi, Chief Economist, GE - Healthcare
Mitch Higashi  

As Chief Economist for GE Healthcare, Mitch Higashi leads a team that is responsible for health economics, global pricing, reimbursement, and health policy. His team seeks to demonstrate the value of healthcare technology by improving cost, quality, and access for all stakeholders. He is based in Chicago, Illinois.


Prior to joining GE, Mitch was the North American Head of Health Economics for GlaxoSmithKline, responsible for the cardiovascular and diabetes portfolio. Mitch served as co-chair for the ISPOR 2007 US meeting and currently serves on the corporate advisory board for the University Of Washington School Of Pharmacy.

As a published author in JAMA, Mitch’s work in molecular diagnostics has been featured in The Wall Street Journal and on National Public Radio. Mitch is a graduate of the University of British Columbia (BSc., Biotechnology) and The Wharton School and he holds a PhD from the University of Washington, Pharmaceutical Outcomes Research & Policy Program.

Lauren Mikulski '09, Worldwide Senior Manager, Point of Care Technologies, BD (Becton, Dickinson & Co.)

Lauren Mikulski is responsible for market sensing, market development and business case analysis for new POC technology solutions in the Global Health product portfolio pipeline and markets. This position adds cross-business and cross-regional support for development of common POC diagnostic product attributes necessary for deployment in developing and emerging countries. Among Ms. Mikulski’s key areas of responsibilities are to interface with the sensing and product development teams across BD’s business areas and R&D teams working in emerging and developing markets.


Prior to this role, Ms. Mikulski was based in Nairobi, Kenya where she led BD’s future efforts for POC go-to-market strategies and green sustainability for diagnostics in developing countries. Ms. Mikulski joined BD in 2009 as a Strategic Manager for Global Health. In this role she was responsible for managing key projects, creating and managing public private partnerships, and providing cross-business strategic marketing support.


Prior to her current role at BD, Ms. Mikulski worked at Johnson & Johnson, (Tibotec Therapeutics), Dell Inc., Cayuga Medical Center, Rockefeller University, and Africare where she lived and worked in Uganda. Ms. Mikulski holds an MBA degree from Kellogg School of Management at Northwestern University. She holds a Bachelor of Science degree in Industrial & Labor Relations from Cornell University.

David Milestone '06, Senior Market Access Advisor, Center for Accelerating Innovation and Impact, USAID
David Milestone  

David Milestone is a Senior Market Access Advisor at the U.S. Agency for International Development’s new Center for Accelerating Innovation and Impact (CAII) in the Global Health Bureau. In this role, Mr. Milestone leads the Market Access team which is focused on the development and implementation of market-based strategies on supply- and demand-side bottlenecks aimed at accelerating the adoption of priority health interventions.


Prior to this role, Mr. Milestone held various strategic marketing roles at Stryker, including leading innovation and strategy initiatives in India. Mr. Milestone has also worked as a management consultant at AT Kearney, an entrepreneurship development consultant with TechnoServe in Ghana and Swaziland, and an English teacher in Costa Rica.


He has an MBA from the Kellogg School of Management at Northwestern University, an MPA from Harvard’s Kennedy School of Government, an MS in Biomechanics from Stanford University, and a BS in Mechanical Engineering from the University of Wisconsin-Madison.


1. How are payers and providers attempting to engage consumers to make better decisions with respect to their health and healthcare?

2. Is transparency of information enough to make a difference, or must the entire incentive structure (e.g. coinsurance instead of copay) change?

3. Can the government put forth any legislation that would make consumers more accountable and willing to behave efficiently?

Cory Capps (Moderator) Managing Director, Bates White
Cory Capps  

A partner at Bates White Economic Consulting in Washington, DC, Cory Capps has more than 15 years of economic experience specializing in industrial organization, empirical methods, and antitrust, with a focus on the healthcare industry. He has advised and offered testimony on behalf of private firms and government agencies on market power and competition in the healthcare sector, including testimony on behalf of the Federal Trade Commission in its successful effort to enjoin the merger of OSF St. Anthony Medical Center and Rockford Health System in Illinois. In addition to Dr. Capps’ broad healthcare experience, he has conducted economic analysis for investigations and cases involving a variety of industries such as airlines, semiconductors, newspapers, online content providers, and agriculture. Previously, Dr. Capps was a Staff Economist at the Antitrust Division of the Department of Justice. He has also served professorships at the University of Illinois at Urbana-Champaign and Northwestern University’s Kellogg School of Management. He has published widely in academic journals, including RAND Journal of Economics; Journal of Economics and Management Strategy; Journal of Health Economics; and Antitrust Bulletin. In 2011, Global Competition Review named Dr. Capps to its International Who’s Who of Competition Economists.

James Gernetzke '12, Director of Business Development, National Research Corporation
James Grenetzke  

James Gernetzke is the Director of New Business Development at National Research Corporation. He leads a team that is dedicated to empowering customer-centric care across the entire healthcare continuum. For more than 30 years, National Research Corporation has been at the forefront of patient-centered care, helping healthcare providers measure and improve quality and service through analytics that offer a rich understanding of customers’ experiences, preferences, risks and behaviors. Today, the company’s focus on customer-centric healthcare extends patient-centered care to incorporate families, communities, employees, and other stakeholders. Prior to National Research Corporation Mr. Gernetzke co-founded, managed, and successfully sold J&M Heritage Imports, LLC, a wine and spirits importer. Mr. Gernetzke also held various leadership positions at a private equity firm in Omaha, Nebraska. Mr. Gernetzke began his career as an officer in the United States Army where he held numerous unique and challenging positions in the Middle East, Europe, and in the U.S. James is a Certified Public Account registered in the state of Illinois and has an MBA from the Kellogg School of Management at Northwestern University. In his spare time, Mr. Gernetzke enjoys blogging about the healthcare customer experience and designing houses with his wife Julie and daughters Sadie, Isabella, Sophie, and Ella.

Sriram Iyer, Founder and CEO, InfoAlchemy
Sriram Iyer  

Expertise: Drug pricing, Health Analytics, Capturing Savings Through Efficiency.


Sriram Iyer has over 15 years of entrepreneurial experience in healthcare and technology and is the current CEO of InfoAlchemy, a company that helps Health Plans drive value by providing web and mobile applications to directly engage their members. Prior to starting InfoAlchemy, he was an Executive Director at The Advisory Board Company, serving 2800+ hospitals and healthcare companies. In this position, Mr. Iyer built a healthcare analytical services business generating over $20M in recurring revenue from health plans. Mr. Iyer reduced the cost of prescription drug coverage by over $20 Per Employee Per Month (PEPM) for over 100,000 employee lives through innovative deployment of Pharmacy Benefit Management services. Mr. Iyer has had numerous other positions in healthcare and technology. He was CEO of a healthcare analytics firm that measured the risks of post-marketing drugs. He also worked at Microsoft, McKinsey & Company, MicroStrategy and Ariel Research. Mr. Iyer has an MBA from The Wharton School of Business and a Bachelors Degree in Computer Science and Economics from Dartmouth College.

Martha Wofford '01, Vice President, Aetna
Martha Wofford  

Martha Wofford leads Aetna’s company-wide CarePass platform, which will deliver an ecosystem of apps powered by an open, digital platform enabling consumers & Aetna members to control their data and manage their whole health. CarePass also supports a developer community to foster creativity in creating consumer solutions.


In her previous positions with Aetna, Ms. Wofford served as Head of Product and Strategy and General Manager for the Northeast Region’s Consumer Segment. Ms. Wofford was honored as the top General Manager and also won the Aetna Chairman’s Leadership Excellence award for her contributions to the corporation. Ms. Wofford joined Aetna in 2005 as Head of Business Development for Medicare to help lead the Prescription Drug Plan business and build Aetna’s national distribution capability.


Prior to joining Aetna, Ms. Wofford was a consultant with Booz Allen Hamilton, focusing on growth strategies in the healthcare and media industries. She served in the Clinton Administration for six years in communications and legislative positions in The White House, USAID and USEPA. Ms. Wofford received an MBA from the Kellogg School of Management at Northwestern University and a B.A. in History from Swarthmore College. At Swarthmore she lettered in 12 varsity sports, was captain of four teams, and achieved national honors in lacrosse.


She resides in Hatfield, MA with her husband and daughter.


1. What are the roles of breakthrough vs. incremental innovation in medical devices and pharmaceuticals today?

2. How can innovation be sustained as regulatory and reimbursement hurdles increase?

3. What will fuel the growth of the industry in the coming decade?

Greg Scott, Partner and Industry Section Leader of Health Plans, Deloitte
Greg Scott  

Greg Scott is the national leader of the nation’s largest health plan consultancy. He has over 22 years of diverse professional experience as management consultant, insurance company executive and government official.


Mr. Scott leads a team of more than 50 partners and directors who help leading health plans and PBMs to address their most critical business and technology challenges and opportunities. His personal areas of industry expertise include health care reform and government health care programs. He is a respected analyst and commentator on federal and state health policy.


Prior to joining Deloitte in 1998, Mr. Scott served in Medicare and Medicaid strategic planning, business development and line management roles with one of the nation’s largest health insurance companies. Previously, he served in policy and financial management roles with the Department of Health and Human Services in Baltimore, MD and Washington, DC.


He is an alumnus of the University of Pittsburgh, where he received both his BA and his MPA. Mr. Scott resides in Pittsburgh, where he is active in his community, including serving as a member of the board of directors of WQD public television and radio.

Michael Hill, VP of Research and Development, Medtronic
Michael Hill  

Michael Hill joined Medtronic in July 1992 as a Scientist in the Cardiac Rhythm Management division of Medtronic in Minneapolis, MN. He has served in research, clinical, program, international and management roles over his twenty years at Medtronic. He is a Technical Fellow (1998) and Bakken Fellow (2001). He now leads the Research and Development efforts for the Heart Failure Business Unit. He holds over 50 patents, has authored several manuscripts and abstracts, and often is an invited lecturer at international cardiac-related conferences and university events.


A native of Jackson, Tennessee, Dr. Hill received his BSE [Biomedical and Electrical Engineering] and BS [Mathematics] Degrees from Duke University, MS and PhD [Biomedical Engineering] Degrees from Case Western Reserve University, and MBA [Management] Degree from the University of St. Thomas.

Erin Huntington, VP of International Corporate Affairs and GPRA, Eli Lilly
Erin Huntington  

Erin Huntington is Vice President of International Corporate Affairs and Global Pricing, Reimbursement and Access (GPRA) for Eli Lilly and Company. She is responsible for Corporate Affairs and product market access for all markets outside the U.S., PRA standards and capability development worldwide, and Global Anti-Counterfeiting Operations.


Ms. Huntington began her career at Lilly in 1997, and has worked in numerous Corporate Affairs, market access, and Government Affairs roles. Most recently, Ms. Huntington led the company’s Global Payer Marketing efforts based from Indianapolis, which was preceded by a five-year assignment in Europe where she served as Corporate Affairs Director for Europe, and as Corporate Affairs Director for Lilly UK. Prior to that, Ms. Huntington worked in Lilly’s Washington, D.C. office in several international government affairs roles.


Before joining Lilly, Ms. Huntington served on the staff of Senator Richard G. Lugar as Legislative Assistant with a focus on foreign policy issues.


Ms. Huntington holds a Bachelor’s degree in Political Science and Spanish from Indiana University, and a Master’s degree in International Affairs from George Washington University. She currently serves on the Board of Directors (Vice Chair) of Girls Incorporated of Greater Indianapolis and as a Torchbearer for United Way of Central Indiana.

Kent Lawson, Head of Global Innovation, Abbott
Kent Lawson  

Kent Lawson joined Abbott in 2011 as Head of Global Innovation. In this role, Mr. Lawson will focus on developing and embedding a culture that identifies innovative solutions to business opportunities throughout the Global Proprietary Pharmaceuticals Division commercial organization.


Prior to joining Abbott, Mr. Lawson was the Global Health and Wellness Practice Lead at IDEO, the world’s leading design and innovation consulting firm. Mr. Lawson was responsible for practice growth and vision across four IDEO offices worldwide. While at IDEO Mr. Lawson worked with many of the world’s top pharmaceutical companies, medical device companies, provider organizations and payers.


Mr. Lawson earned his Bachelor’s degree in Industrial Design from University of Illinois at Urbana. He currently serves on the Board of Directors for Liberty Prairie Conservancy, the largest land-trust conservancy in Lake County, Illinois where he lives with his wonderful wife, four kids, three dogs and two birds.

Joseph Leveque, MD, Vice President and Head of US Medical - Oncology, Bristol Myers Squibb

Joseph A. Leveque, MD, is the Vice President of US Medical – Oncology at Bristol Myers-Squibb (BMS) in Princeton, NJ. He is responsible for providing strategic leadership and management of an integrated medical team focused on the Company’s ImmunoOncology in-line and pipeline assets.


Prior to joining BMS, Dr. Leveque was Vice President of Medical and Scientific Affairs (MedSA) at Onyx Pharmaceuticals where he was focused on the development of Kyprolis (carfilzomib), a next-generation proteasome inhibitor for the treatment of multiple myeloma and Nexavar, a targeted therapy for a multitude of solid tumors. Prior to joining Onyx Pharmaceuticals, Dr. Leveque was the Vice President, Oncology MedSA at Cephalon where he led all medical and scientific activities supporting the launch of Treanda for the treatment of CLL and NHL. Dr. Leveque was also Medical Director/Global Development Lead for Nplate and Neulasta at Amgen.


Dr. Leveque received his medical degree from the University of Texas Medical School and his post-graduate medical training in internal medicine and critical care at UCLA. Dr. Leveque also holds an Master’s in Business Administration from The Wharton School at the University of Pennsylvania and a Bachelor of Sciences in biology and mathematics from the Santa Clara University.



1. What type of healthcare projects/technologies are attractive investment opportunities? How has this changed in the last five years?

2. What are VC/PE firms currently focusing on? Have investment criteria changed?

3. What challenges do start-up companies in the healthcare space face related to funding? How can these barriers be best addressed?

William Sutter, (Moderator) Professor, Kellogg School of Management
William Sutter  

William P. Sutter, Jr. is a Senior Lecturer of Finance and a member of Kellogg’s Larry and Carol Levy Institute for Entrepreneurial Practice. He teaches Venture Capital and Private Equity – The Human Element (ENTR 926), NUvention Medical Innovation (HEMA 915), and Global Governance of Private Companies (ENTR 965). 

 Professor Sutter is a founder of Wildcat Angels and manages the student Associates program for screening deal flow.


Professor Sutter is also a Partner of Hopewell Ventures, a $106 million venture capital fund with an investment focus on high-growth companies located in the Midwest. Hopewell has completed fifteen investments ranging from medical device manufacturers to alternative media companies.


Before becoming a founder of Hopewell, Professor Sutter was a Senior Managing Director of Mesirow Financial’s Private Equity division. During his 17-year tenure, capital under management grew to $300 million, and his successful track record comprised investments in 29 portfolio companies, including four that completed an IPO. He started his career as an investment banker with the Corporate Finance department of Smith Barney.


Professor Sutter graduated from Yale University with a B.A. degree in Economics and received his M.B.A. from Stanford University. His interests include scuba diving, military history, and blues guitar.

Greg Moerschel '96, Partner, Beecken Petty O’Keefe & Company
Greg Moerschel  

Prior to joining Beecken Petty O’Keefe & Company as a Partner in 1997, Mr. Moerschel was vice president and Senior Healthcare analyst for ABN AMRO North America from 1994 to 1997. Prior to that, from 1990 to 1994, he was a member of the healthcare investment banking group at First Chicago (now JP Morgan Chase) and a related joint venture, where he worked with Dave Beecken and Ken O’Keefe.


Mr. Moerschel serves or has served on the board of directors of Genezen Healthcare, Genoa Healthcare Holdings, Hospital Physician Partners, Preferred Homecare, The Hygenic Corporation, NetRegulus, NeuroSource, RSA Medical, Take Care Health Systems, and TIDI Products.


Mr. Moerschel received a B.A. degree in economics from Northwestern University and an M.B.A. degree in finance and health services administration from the Kellogg School of Management at Northwestern University.

Kristin Myers, Principal Arboretum Ventures

Kristin Myers joined Arboretum Ventures in 2012 as a Principal and is responsible for sourcing and leading new investment opportunities as well as supporting existing portfolio companies. Previously, Ms. Myers worked at Skyline Ventures in Palo Alto, CA starting in 2008 where she sourced and led new investment opportunities and supported portfolio companies. She served on the Board of Directors at Medivance, a therapeutic cooling company, before its acquisition by Bard in 2011 and supported multiple new investments including SI Bone, an orthopedic company, where she was a board observer.

Prior to her investing experience, Ms. Myers spent nearly 7 years working in the medical device industry, specifically focused in cardiology. She spent 5 years working in Medtronic’s Cardiac Rhythm Management division first in product development, then in marketing and then in sales in New York City. Previous to her time at Medtronic, Ms. Myers worked for Guidant’s Drug Eluting Stent division (now Abbott), Guidant’s Cardiac Rhythm Management division (now Boston Scientific) and for Abiomed’s Total Artificial Heart program. She has authored multiple patents during her career.


Ms. Myers earned a BS in Biomedical Engineering from the University of Wisconsin-Madison and an MBA from Harvard University.

Evan Norton '02, Director, Abbott Ventures

Evan Norton joined Abbott Ventures in 2010. Prior to Abbott Ventures, he was a Principal with ONSET Ventures focused on medical technology investing. He has a diverse background of operating experience in medical technology including the endoscopy, diabetes and ear, nose and throat markets having worked for Stryker Endoscopy, J&J LifeScan and Acclarent.

In addition to his medical device experience, Mr. Norton worked for Compaq Computer Corporation’s Strategic Investments group, the Investment Banking Group at J.P. Morgan Chase & Co and in the consulting practice at PriceWaterhouseCoopers.

Mr. Norton holds an MBA degree from the Kellogg School of Management at Northwestern University and a BBA in Finance from Texas A&M University. He currently serves on the Innovation and New Ventures Advisory Board at Northwestern University as well as the Oversight Committee for the Coulter Translational Partnership Program at the University of Missouri.


1. How has design thinking in healthcare evolved in the last 5 years? Now with the changing healthcare landscape - how do they envision it evolving in the coming 5 years?

2. What will be the key innovations that will drive design in healthcare?

3. How do healthcare firms embrace design thinking in an industry where the consumer experience is so particularly unique and holistic?

Greg Holderfield (Moderator) Director of the Segal Design Institute, Co-Director of the MMM program, Northwestern University

Greg Holderfield is the Director of the Segal Design Institute. He is a human-centered design educator and practitioner who’s work has been recognized globally with more than 25 design and innovation awards, including two German “Red Dot” awards, the Japanese “Good Design” award, and the IF International Design Forum award. He also has received four “Intentional Design Excellence Awards” (IDEA) presented jointly by BusinessWeek and the Industrial Design Society of America (IDSA). His work has been exhibited in galleries across the nation and has also been published in the Wall Street Journal, BusinessWeek, Forbes, and Wired.


Professor Holderfield teaches both undergraduate and graduate design courses at Northwestern University and co-directs the MMM program, which is a joint degree program with the Kellogg School of Management and the McCormick School of Engineering and Applied Science. As an innovative thought leader, he has collaborated with the Mayo Clinic, P&G, McDonald’s, Dell, Microsoft, 3M, SC Johnson and Sons, Wrigley, Unilever and LG Electronics. In 2011, he was appointed to the steering committee for the Edison Innovation Awards.

Maggie Breslin, Designer, Smaller Sanities Design & Research

Maggie Breslin is a designer and researcher with a unique focus in healthcare delivery although she does work in other fields as well. She pioneered the role of designer/researcher at Mayo Clinic’s Center for Innovation when she joined in 2005 and helped build the program until she left in 2011 to establish her own practice, Smaller Sanities Design & Research. She leads research, design and development efforts around topics as diverse as decision-making, risk communication, integrated practice models, remote care, caregiving and minimally disruptive medicine. She believes strongly that good conversation is key to transforming healthcare delivery and champions this idea in all her work. She has logged many hours observing and talking to patients and clinicians and counts those opportunities as among her most treasured.


She has published in journals ranging from Design Issues to Archives of Internal Medicine and had a previous life in film/television/animation/motion graphics where she learned how to tell stories. Ms. Breslin holds a Masters of Design (MDes) from Carnegie Mellon University and a BS in Mass Communications, Film and Television, from Miami University, Oxford, Ohio.

Evren Eryurek, CTO, GE Healthcare IT & Performance Solutions

Evren Eryurek is a Chief Technology Officer for GE Healthcare IT & Performance Solutions, a $1.4 billion segment of GE Healthcare. GE Healthcare IT/PS is a global leader in delivering information technology solutions that support high-quality and cost-effective care through business, clinical, and imaging solutions covering settings from the physician office to the integrated delivery network.


Mr. Eryurek is responsible for leading all technology activities that drive customer success and deliver improved patient outcomes. He oversees all research and development, global technical governance and aligment of technology vision and business strategy across the HCIT/PS portfolio. Several initiatives he is championing and driving across GE Healthcare include the formation of the Software and User Experience Centers of Excellence (COEs), as well as the adoption of Agile methodology in the software development process. Mr. Eryurek is a member of GE’s Software Council representing GE Healthcare.

Mr. Eryurek is a graduate of the University of Tennessee, where he earned a master’s and doctorate degree in Nuclear Engineering. He holds over 50 US patents. Mr. Eryurek lives in the Seattle area with his wife and two children.



Larry Keeley, Founder and Partner, Doblin

Larry Keeley is a strategist who has worked for thirty years to develop more effective innovation methods. Mr. Keeley is President and co-founder of Doblin Inc, an innovation strategy firm known for pioneering comprehensive innovation systems that materially improve innovation success rates. Doblin is now a member of Monitor Group, Cambridge MA, where Mr. Keeley is a Group Leader.


Mr. Keeley teaches graduate innovation strategy classes at the Institute of Design in Chicago, the first design school in the U.S. with a Ph.D. program, where he is also a board member. He lectures in executive education programs at Kellogg School of Management and is an adjunct faculty member for their core MBA and their Masters of Manufacturing Management programs. He also lectures at University of Chicago, plus business schools in Spain, England, Scotland and China. Mr. Keeley was a Senior Fellow of the Center for Business Innovation, in Boston. He is also a board member for Chicago Public Radio, where he has charted strategy for what has become an innovation engine for public radio across the US—helping to foster “This American Life” and other path breaking new radio programs and media innovations.

Joshua Riff, MD, VP Clinical Retail Strategy, WellPoint

Joshua Riff, MD, MBA is a board certified emergency medicine physician living in Minneapolis, MN. He is currently the Vice President of Retail Clinical Strategy at WellPoint where he is responsible for creating the strategy and leading operations for the retail and convenient care line of business. In his role he leads innovation, strategic partnerships and business development in the retail health and worksite wellness space for WellPoint. He is responsible for developing solutions that improve access to care and quality of care to consumers. His work at WellPoint stems from his passion to develop a consumer focus in order to make healthcare more affordable, understandable, and accessible. Prior to joining WellPoint he was Chief Medical Director of Target Corporation where he had clinical responsibilities over its 1700 pharmacies, 44 retail clinics, and 350,000 employees. He completed his emergency residency training at Johns Hopkins Hospital and his MD/MBA at Tufts University. He is married with three children and still practices emergency medicine in St. Paul.